These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 3732045)
21. Phase 0 clinical trials in oncology: a paradigm shift for early drug development? Takimoto CH Cancer Chemother Pharmacol; 2009 Mar; 63(4):703-9. PubMed ID: 18615251 [TBL] [Abstract][Full Text] [Related]
22. Controlled prophylactic trials in cancer. Magnus K; Miller AB J Natl Cancer Inst; 1980 Apr; 64(4):693-9. PubMed ID: 6928983 [No Abstract] [Full Text] [Related]
23. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials. Dilts DM; Sandler AB J Clin Oncol; 2006 Oct; 24(28):4545-52. PubMed ID: 17008693 [TBL] [Abstract][Full Text] [Related]
24. [Clinical research and informed consent. Ethical and deontologic aspects]. Hoerni B Bull Cancer; 1997 Mar; 84(3):311-2. PubMed ID: 9207878 [No Abstract] [Full Text] [Related]
25. [Ethics of randomization]. Arpaillange P; Dion S Biomed Pharmacother; 1984; 38(9-10):426-9. PubMed ID: 6529599 [No Abstract] [Full Text] [Related]
26. [Ethics symposium. 2-3 April 2007, Paris, France. Foreword]. Ahouanto M Bull Soc Pathol Exot; 2008 Apr; 101(2):75-6. PubMed ID: 18543696 [No Abstract] [Full Text] [Related]
29. [Huriet's law in cancerology. Ethical debate about informed consent of the patient]. Flamant R Bull Cancer; 1993 Oct; 80(10):892-3. PubMed ID: 8204929 [No Abstract] [Full Text] [Related]
30. [Huriet's law in cancerology. Psychological and relationship problems from the oncologist's point of view]. Piguet H Bull Cancer; 1993 Oct; 80(10):894-6. PubMed ID: 8204930 [No Abstract] [Full Text] [Related]
31. Methodological and ethical difficulties in clinical oncology trials. Di Bella Multitreatment Italian Trial Coordinating Group. Raschetti R; Bruzzi P Lancet; 1999 Jan; 353(9147):153-4. PubMed ID: 10023931 [No Abstract] [Full Text] [Related]
32. Principles and problems of clinical trials: a European view. Tygstrup N Triangle; 1980; 19(3-4):93-6. PubMed ID: 7222225 [No Abstract] [Full Text] [Related]
33. The ethical approach to phase I clinical trials in oncology. Durry G; Dion S Drugs Exp Clin Res; 1986; 12(1-3):21-2. PubMed ID: 3732049 [No Abstract] [Full Text] [Related]
34. The ethical approach to phase II clinical trials in oncology. Dion S Drugs Exp Clin Res; 1986; 12(1-3):41-2. PubMed ID: 3732053 [No Abstract] [Full Text] [Related]
35. Problems and challenges in randomized trials: a commentary. Feinstein AR Triangle; 1980; 19(3-4):77-81. PubMed ID: 7222222 [No Abstract] [Full Text] [Related]
36. The ethics of placebo-controlled trials for perinatal transmission of HIV in developing countries. Clark PA AIDS Public Policy J; 1998; 13(1):20-9. PubMed ID: 10915269 [No Abstract] [Full Text] [Related]
37. Review article: Controlled clinical trials. Pollock AV Life Support Syst; 1983; 1(4):227-33. PubMed ID: 6679017 [No Abstract] [Full Text] [Related]
38. Assessment of toxicity in cooperative oncology clinical trials: the long and short of it. Gwede CK; Johnson DJ; Daniels SS; Trotti A J Oncol Manag; 2002; 11(2):15-21. PubMed ID: 11989815 [TBL] [Abstract][Full Text] [Related]
39. [Clinical trials. Methodological principles and ethical aspects in the evaluation of therapies]. Montagne O; Macquin-Mavier I; Lejonc JL Rev Prat; 1998 Mar; 48(6):679-84. PubMed ID: 9781143 [No Abstract] [Full Text] [Related]
40. [Huriet's law in cancerology. Psychological consequences of Huriet's law in oncologic units]. Alby N Bull Cancer; 1993 Oct; 80(10):897-9. PubMed ID: 8204931 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]